Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Toxicol Rep
.
2020 Apr 30:7:658-663.
doi: 10.1016/j.toxrep.2020.04.012.
eCollection 2020.
Authors
Konstantinos Farsalinos
1
2
,
Raymond Niaura
3
,
Jacques Le Houezec
1
,
Anastasia Barbouni
2
,
Aristidis Tsatsakis
4
,
Dimitrios Kouretas
5
,
Apostolos Vantarakis
6
,
Konstantinos Poulas
1
Affiliations
1
Laboratory of Mol. Biology and Immunology, Department of Pharmacy, University of Patras, Panepistimiopolis, 26500, Greece.
2
School of Public Health, Department of Public and Community Health, University of West Attica, 11521, Greece.
3
Departments of Social and Behavioral Science and Epidemiology, College of Global Public Health, New York University, USA.
4
Department Medicine, University of Crete, Greece.
5
Department of Biochemistry and Biotechnology, University of Thessaly, Larisa, 41500, Greece.
6
School of Medicine, University of Patras, Panepistimiopolis, 26500, Greece.
PMID:
32355638
PMCID:
PMC7192087
DOI:
10.1016/j.toxrep.2020.04.012
No abstract available
Publication types
Editorial